Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

X-linked hypophosphatemia.

R A Meyer1, W F Conway, J C Chan

  • 1Department of Basic Sciences, Marquette University School of Dentistry, Milwaukee, WI 53233.

Seminars in Nephrology
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A low socio-economic status is an additional risk factor for glucose intolerance in high risk Hong Kong Chinese.

European journal of epidemiology·2001
Same author

Change of glycaemic status in Chinese subjects with impaired fasting glycaemia.

Diabetic medicine : a journal of the British Diabetic Association·2001
Same author

Important role of cardiac spect imaging in patients undergoing percutaneous transluminal coronary angioplasty.

Chinese medical journal·2001
Same author

Diabetes mellitus--a special medical challenge from a Chinese perspective.

Diabetes research and clinical practice·2001
Same author

Obesity, insulin resistance and isolated low high-density-lipoprotein cholesterol in Chinese subjects.

Diabetic medicine : a journal of the British Diabetic Association·2001
Same author

Consultation with the specialist: renal tubular acidosis.

Pediatrics in review·2001
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

X-linked hypophosphatemia causes rickets due to impaired phosphate reabsorption. Mouse models with similar gene defects offer insights into this metabolic bone disease and potential new treatments.

Area of Science:

  • Genetics
  • Metabolic Bone Diseases
  • Pediatric Endocrinology

Background:

  • X-linked hypophosphatemia is a prevalent cause of metabolic rickets in children.
  • The genetic defect is mapped to the Xp22 region in humans.
  • Similar syndromes in mice (Hyp and Gy genes) aid research.

Purpose of the Study:

  • To summarize the current understanding of X-linked hypophosphatemia.
  • To highlight the utility of mouse models in studying this disorder.
  • To explore potential therapeutic avenues.

Main Methods:

  • Review of genetic and clinical data for human X-linked hypophosphatemia.
  • Characterization of mouse models (Hyp and Gy) with similar phenotypes.
  • Analysis of renal phosphate handling and vitamin D metabolism.

Related Experiment Videos

Main Results:

  • Both human and mouse models exhibit low renal tubular phosphate reabsorption, rickets, and osteomalacia.
  • 1,25-dihydroxyvitamin D synthesis is unresponsive to low phosphate in affected individuals and mice.
  • The precise molecular defects remain unidentified in both humans and mouse models.

Conclusions:

  • Murine models of X-linked hypophosphatemia are valuable tools for understanding the pathophysiology.
  • These models provide a platform for testing novel therapeutic strategies for rickets and osteomalacia.
  • Further research is needed to elucidate the underlying genetic defects.